<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="iso-abbrev">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Mediators of Inflammation</journal-title></journal-title-group><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5350351</article-id><article-id pub-id-type="doi">10.1155/2017/8529542</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-Defensin 3</z:uniprot> Reduces <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-Induced Inflammation and Monocyte Adhesion in Human Umbilical Vein Endothelial Cells </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bian</surname><given-names>Tianying</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Houxuan</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ni</surname><given-names>Can</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yangheng</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5632-9487</contrib-id><name><surname>Yan</surname><given-names>Fuhua</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Periodontology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China</aff><aff id="I2"><sup>2</sup>Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China</aff><aff id="I3"><sup>3</sup>Department of Endodontics, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China</aff><author-notes><corresp id="cor1">*Fuhua Yan: <email>fhyan2005@126.com</email></corresp><fn fn-type="other"><p><text><SENT sid="1" pm="."><plain>Academic Editor: Ulrich Eisel </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>2</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>8529542</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2016</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>Copyright © 2017 Tianying Bian et al.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>The aim of this study was to investigate the role of human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>) in the initiation stage of atherosclerosis with human umbilical vein endothelial cells (HUVECs) triggered by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">tumor necrosis factor</z:uniprot>- (<z:uniprot sup="inside" fb="82" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,Q8MKG8,P23383,P79374,Q539C2,Q9BEA1">TNF</z:uniprot>-) α. </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial injury and inflammatory response were evaluated. </plain></SENT>
<SENT sid="4" pm="."><plain>Our data revealed that first, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> reduced the production of <z:uniprot sup="inside" fb="0" ids="P26892,Q6V919,Q2MH06,Q865W7,P41323,Q28319,P46650,Q90YI0,Q9XT80,P41683,Q95181,P05231,Q865X6,P79341,P51494,Q5I6E3,O35736,P08505,A3FBE9,P41693,Q0GGL7,Q28747,A0S0B0,Q28819,P26893,Q9MZR1,P20607,Q8MKH0,P29455,B6CKP4,Q6L6X6,Q25BC2">interleukin-6</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="P26892,Q6V919,Q2MH06,Q865W7,P41323,Q28319,P46650,Q90YI0,Q9XT80,P41683,Q95181,P05231,Q865X6,P79341,P51494,Q5I6E3,O35736,P08505,A3FBE9,P41693,Q0GGL7,Q28747,A0S0B0,Q28819,P26893,Q9MZR1,P20607,Q8MKH0,P29455,B6CKP4,Q6L6X6,Q25BC2">IL-6</z:uniprot>), <z:uniprot sup="inside" fb="0" ids="P79255,P41324,P49113,P46653,P08317,Q102R3,Q9XSX5,O62812,P10145,P67813,P67814,P26894,P19874,P36925,Q7YRB5">IL-8</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">monocyte chemoattractant protein-1</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q4U3U9,P28291,P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">MCP-1</z:uniprot>), and <z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">macrophage migration inhibitory factor</z:uniprot> (<z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot>) in HUVECs in a dose-dependent manner. </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> significantly prevented intracellular reactive oxygen species (ROS) production by HUVECs. </plain></SENT>
<SENT sid="6" pm="."><plain>Second, western blot analysis demonstrated that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> dose-dependently suppressed the protein levels of intracellular adhesion molecule-1 (<z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot>) and vascular <z:uniprot sup="inside" fb="0" ids="Q9BY67,Q8R5M8,Q6AYP5">cell adhesion molecule-1</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot>) in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced HUVECs. </plain></SENT>
<SENT sid="7" pm="."><plain>As a result, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> inhibited monocyte adhesion to <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-treated endothelial cells. </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> suppressed <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> reorganization in HUVECs. </plain></SENT>
<SENT sid="9" pm="."><plain>Third, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> markedly inhibited NF-κB activation by decreasing the phosphorylation of <z:uniprot sup="inside" fb="0" ids="Q95KV1,Q5ZJB4,Q4G3H4,O15111,Q60680,Q6GM53,Q28DZ1">IKK-α</z:uniprot>/β, IκB, and <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> subunit within 30 min. </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, the phosphorylation of <z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot> and c-Jun N-<z:uniprot sup="inside" fb="0" ids="Q1HVJ2,P13285,P0C729,Q37988,P03681">terminal protein</z:uniprot> kinase (<z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot>) in the <z:uniprot sup="inside" fb="0" ids="Q00859">mitogen-activated protein kinase</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot>) pathway were also inhibited by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> in HUVECs. </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> exerts anti-inflammatory and antioxidative effects in endothelial cells in response to <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> by inhibiting NF-κB and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> signaling. </plain></SENT>
</text></SecTag></p></abstract><funding-group><award-group><funding-source xlink:href="http://dx.doi.org/10.13039/501100001809">National Natural Science Foundation of China</funding-source><award-id>81371152</award-id></award-group></funding-group></article-meta></front><body><SecTag type="INTRO"><sec id="sec1"><title><text><SENT sid="12" pm="."><plain>1. </plain></SENT>
<SENT sid="13" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="14" pm="."><plain>Atherosclerosis is a vascular inflammatory disease characterized by the accumulation of lipids and immune cells on the inner face of the arterial wall. </plain></SENT>
<SENT sid="15" pm="."><plain>Inflammatory stimulation, even low level endotoxemia, can aggravate the progression of this disease [1]. </plain></SENT>
<SENT sid="16" pm="."><plain>A monolayer of endothelial cells, which directly contacts the flowing blood, is easily attacked by various stimulating factors. </plain></SENT>
<SENT sid="17" pm="."><plain>Endothelial cell dysfunction triggered by such stimulations is believed to be the initiation step and key contributor in the pathogenesis of atherosclerosis [2]. </plain></SENT>
<SENT sid="18" pm="."><plain>Endothelial cells at sites of inflammation are not only participants but also regulators of inflammation [3, 4]. </plain></SENT>
<SENT sid="19" pm="."><plain>During inflammation, a large amount of inflammatory mediators are produced by immune cells, such as macrophages, and endothelial cells are the main targets. </plain></SENT>
<SENT sid="20" pm="."><plain>Then, the activated endothelial cells secrete a broad spectrum of cytokines and chemokines, recruiting monocytes. </plain></SENT>
<SENT sid="21" pm="."><plain>Enhanced migration and adhesion of monocytes to the endothelium are suggested to play a crucial role in atherosclerosis. </plain></SENT>
<SENT sid="22" pm="."><plain>In addition, the expression of adhesion molecules required for the firm binding of monocytes is also upregulated on endothelial cell surfaces [5]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>In our previous study, the results demonstrated that chronic exposure to the endotoxin of Porphyromonas gingivalis can aggravate atherosclerotic lesions in <z:uniprot sup="inside" fb="0" ids="P0DSE0,P0DMT6,P0DKW5,P0DTT1,P0DKW6,P0DML7,P0DN41,Q03247,P0DOC3,P18649,P0DN38,P23529,P0DOA3,A0A0D9S1R0,P0DKU9,P0DTT2,Q9GLM8,P02649,Q9GLM6,P0DML8,P10517,Q28502,P0DO94,P08226,A0A2Y9GHM3,P0DML9,P0DN39,Q9GJU3,P05770,P0DKY2,P0DMM0,P18650,P0DKW7,Q9GLM7,P18287,P02650,P0DO95,P0DKW8,Q28995,Q7M2U8,P0DTR8,Q9GLC0,P0DMM1,Q7M2U7">ApoE</z:uniprot>-deficient mice [6]. </plain></SENT>
<SENT sid="24" pm="."><plain>Indeed, compelling evidence has demonstrated the proatherogenic role of inflammatory cytokines in the pathogenesis of atherosclerosis. </plain></SENT>
<SENT sid="25" pm="."><plain>Elevated levels of several inflammatory markers in the circulation are risk factors for atherosclerotic events [7]. </plain></SENT>
<SENT sid="26" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">Tumor necrosis factor</z:uniprot>-α (<z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>), one of the most potent inflammatory cytokines, is closely associated with atherosclerosis. </plain></SENT>
<SENT sid="27" pm="."><plain>It is mainly produced by activated macrophages. </plain></SENT>
<SENT sid="28" pm="."><plain>It is a pleiotropic cytokine mediating inflammation, immunity, and apoptosis. </plain></SENT>
<SENT sid="29" pm="."><plain>For vascular endothelial cells, exposure to <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> triggers several signaling cascades in human umbilical vein endothelial cells (HUVECs), especially the nuclear factor κB (NF-κB), c-Jun N-terminal kinase (<z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot>), and <z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot> <z:uniprot sup="inside" fb="0" ids="Q00859">mitogen-activated protein kinase</z:uniprot> pathways, leading to the production of inflammatory cytokines [8]. </plain></SENT>
<SENT sid="30" pm="."><plain>In addition, <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> can reorganize the F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> cytoskeleton of endothelial cells, leading to the formation of stress fibers [9]. </plain></SENT>
<SENT sid="31" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> can also modulate EC permeability by enlarging intercellular gaps, promoting vascular leakage at sites of inflammation [10]. </plain></SENT>
</text></p><p><text><SENT sid="32" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> stimulation is also associated with increased intracellular levels of reactive oxygen species (ROS) formation, enhancing monocyte recruitment and adhesion to the vascular endothelium. </plain></SENT>
<SENT sid="33" pm="."><plain>This process is mediated mainly by elevated cell adhesion molecules such as <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">intercellular adhesion molecule-1</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot>), vascular <z:uniprot sup="inside" fb="0" ids="Q9BY67,Q8R5M8,Q6AYP5">cell adhesion molecule-1</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot>), and endothelial cell selectin (<z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot>). </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q86QN6,Q86QI5,P85213,P80154,Q17027,P81462,C0HJX7,P36192,B2D2C0,O96049,P80407,P83404,P37364,Q86LE4,Q10745,Q5BU36,Q8WQZ3">Defensins</z:uniprot> are naturally occurring peptides with a wide range of antimicrobial, antiviral, and immunomodulatory properties. </plain></SENT>
<SENT sid="35" pm="."><plain>They are cationic, cysteine-rich, β-sheet, and tridisulfide peptides. </plain></SENT>
<SENT sid="36" pm="."><plain>In humans, <z:uniprot sup="inside" fb="0" ids="Q86QN6,Q86QI5,P85213,P80154,Q17027,P81462,C0HJX7,P36192,B2D2C0,O96049,P80407,P83404,P37364,Q86LE4,Q10745,Q5BU36,Q8WQZ3">defensins</z:uniprot> are classified into two categories, α- and <z:uniprot sup="inside" fb="0" ids="P86385">β-defensins</z:uniprot>. <z:uniprot sup="inside" fb="0" ids="P86385">β-defensins</z:uniprot> are mainly produced by the mucosa and epithelial cells. </plain></SENT>
<SENT sid="37" pm="."><plain>Intraocular tissues and the human endometrium are also reported to express <z:uniprot sup="inside" fb="0" ids="P86385">β-defensins</z:uniprot> [11]. </plain></SENT>
<SENT sid="38" pm="."><plain>Several studies have documented the participation of <z:uniprot sup="inside" fb="0" ids="B3EWR6,O24006">antimicrobial peptides</z:uniprot> in endothelial immune defense [12, 13]. </plain></SENT>
<SENT sid="39" pm="."><plain>In addition, <z:uniprot sup="inside" fb="0" ids="P86385">β-defensins</z:uniprot> are beneficial for wound healing of endothelial cells [14]. </plain></SENT>
<SENT sid="40" pm="."><plain>Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>) is a member of the <z:uniprot sup="inside" fb="0" ids="P86385">β-defensin</z:uniprot> family. </plain></SENT>
<SENT sid="41" pm="."><plain>In addition to epithelial cells, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> is also expressed in endothelial cells. </plain></SENT>
<SENT sid="42" pm="."><plain>The gene and protein expression of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> are induced in human umbilical vein endothelial cells simulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> [15]. </plain></SENT>
<SENT sid="43" pm="."><plain>The upregulation of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> in HUVECs illustrates the important role that <z:uniprot sup="inside" fb="0" ids="Q86QN6,Q86QI5,P85213,P80154,Q17027,P81462,C0HJX7,P36192,B2D2C0,O96049,P80407,P83404,P37364,Q86LE4,Q10745,Q5BU36,Q8WQZ3">defensins</z:uniprot> play in host immune defense against inflammation. </plain></SENT>
<SENT sid="44" pm="."><plain>In our previous study, we demonstrated that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> strongly inhibited the progression of early-stage atherosclerotic lesions and inflammation levels in RAW 264.7 cells and human <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1-derived macrophages [16, 17]. </plain></SENT>
</text></p><p><text><SENT sid="45" pm="."><plain>However, the cell types targeted by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> might not be restricted to macrophages. </plain></SENT>
<SENT sid="46" pm="."><plain>Vascular endothelial cells and monocytes/macrophages are both atherogenic and critical components in the process of atherogenesis [18]. </plain></SENT>
<SENT sid="47" pm="."><plain>The interaction between macrophages and endothelial cells is very crucial in atherosclerosis. </plain></SENT>
<SENT sid="48" pm="."><plain>In normal conditions, resting endothelial cells form an integrated barrier at the blood-tissue interface. </plain></SENT>
<SENT sid="49" pm="."><plain>Upon inflammatory stimulation, quiescent endothelial cells may transform into a proatherogenic phenotype, inducing the infiltration of monocytes [19]. </plain></SENT>
<SENT sid="50" pm="."><plain>The recruited monocytes then differentiate into macrophages, contributing to a vicious cycle promoting endothelial dysfunction [20]. </plain></SENT>
<SENT sid="51" pm="."><plain>As the endothelium has already been a therapeutic target, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> might also manifest its protective effects by interacting with vessel endothelial cells. </plain></SENT>
<SENT sid="52" pm="."><plain>The effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial cell activation remain unknown. </plain></SENT>
</text></p><p><text><SENT sid="53" pm="."><plain>Thus, the present study was designed to focus on the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-stimulated endothelial cell dysfunction, including the enhanced production of inflammatory mediators, monocyte adhesion, and the expression of cell adhesion molecules, all of which are early events in the pathogenesis of atherosclerosis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec2"><title><text><SENT sid="54" pm="."><plain>2. </plain></SENT>
<SENT sid="55" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="sec2.1"><title><text><SENT sid="56" pm="."><plain>2.1. </plain></SENT>
<SENT sid="57" pm="."><plain>Cell Culture and Reagents </plain></SENT>
</text></title><p><text><SENT sid="58" pm="."><plain>Human primary umbilical vein endothelial cells (HUVECs) (ScienCell Research Laboratories, San Diego, CA) were maintained in endothelial cell medium (ECM) (ScienCell Research Laboratories) supplemented with 5% FBS, 1% penicillin/streptomycin, and 1% endothelial cell growth supplement (ECGS). </plain></SENT>
<SENT sid="59" pm="."><plain>For the present study, cells at passages 3–6 were seeded and grown until confluence. </plain></SENT>
</text></p><p><text><SENT sid="60" pm="."><plain>Recombinant human <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> were obtained from PeproTech (Rocky Hill, NJ, USA). </plain></SENT>
<SENT sid="61" pm="."><plain>Anti-<z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and anti-<z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). </plain></SENT>
<SENT sid="62" pm="."><plain>Antiphosphorylated and total IκBα, <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot>, <z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot>, <z:uniprot sup="inside" fb="13" ids="P29323">ERK</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot> antibodies were purchased from Cell Signaling Technology (Beverly, MA). </plain></SENT>
</text></p></sec><sec id="sec2.2"><title><text><SENT sid="63" pm="."><plain>2.2. </plain></SENT>
<SENT sid="64" pm="."><plain>Cell Viability Assay </plain></SENT>
</text></title><p><text><SENT sid="65" pm="."><plain>The cell viability of HUVECs was determined using a <z:uniprot sup="inside" fb="2" ids="O93464">CCK8</z:uniprot> assay according to the manufacturer's instructions. </plain></SENT>
<SENT sid="66" pm="."><plain>HUVECs (5000 cells/well) were prepared in 96-well plates and incubated overnight before treatment with various concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (20, 10, 5, 2.5, or 1.25 μg/mL) and <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) for 24 h. </plain></SENT>
<SENT sid="67" pm="."><plain>Subsequently, 10 μL of <z:uniprot sup="inside" fb="2" ids="O93464">CCK8</z:uniprot> solution (Dojindo Laboratories, Kumamoto, Japan) was added to each well, and the cells were incubated for an additional 3 h. </plain></SENT>
<SENT sid="68" pm="."><plain>The optical density of each well was evaluated at a wavelength of 450 nm on a microplate spectrophotometer. </plain></SENT>
</text></p></sec><sec id="sec2.3"><title><text><SENT sid="69" pm="."><plain>2.3. </plain></SENT>
<SENT sid="70" pm="."><plain>Enzyme-Linked Immunosorbent Assay (ELISA) </plain></SENT>
</text></title><p><text><SENT sid="71" pm="."><plain>HUVECs were seeded and cultured in a 96-well plate until confluent. </plain></SENT>
<SENT sid="72" pm="."><plain>The control group was treated with ECM and the other seven groups were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) in the presence of various concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h. </plain></SENT>
<SENT sid="73" pm="."><plain>Then the cell supernatants were collected by centrifugation. </plain></SENT>
<SENT sid="74" pm="."><plain>The assay was performed with specific ELISA kits (R&amp;D Systems) according to the manufacturer's recommendations. </plain></SENT>
</text></p></sec><sec id="sec2.4"><title><text><SENT sid="75" pm="."><plain>2.4. </plain></SENT>
<SENT sid="76" pm="."><plain>Monocyte Adhesion Assay </plain></SENT>
</text></title><p><text><SENT sid="77" pm="."><plain>Confluent HUVECs were stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) in the presence or absence of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h. </plain></SENT>
<SENT sid="78" pm="."><plain>After that, the cells were washed with RPMI-1640 medium before being cocultured with <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells. </plain></SENT>
<SENT sid="79" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells were prelabeled with 2 μM calcein-AM (Dojindo Laboratories) in RPMI-1640 medium for 20 min in the cell incubator before being added to each well of HUVECs and further incubated for 30 min. </plain></SENT>
<SENT sid="80" pm="."><plain>After coincubation, each well was washed gently and thoroughly with RPMI-1640 medium supplemented with 1% FBS to remove the nonadherent <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells. </plain></SENT>
<SENT sid="81" pm="."><plain>The attached <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells were examined under a microscope (Olympus Corporation, Tokyo, Japan) and fluorescence microplate reader at excitation and emission wavelengths of 490 nm and 515 nm. </plain></SENT>
</text></p></sec><sec id="sec2.5"><title><text><SENT sid="82" pm="."><plain>2.5. </plain></SENT>
<SENT sid="83" pm="."><plain>Western Blot Analysis </plain></SENT>
</text></title><p><text><SENT sid="84" pm="."><plain>The cells were lysed in <z:uniprot sup="inside" fb="58" ids="Q6NI56,Q8FQS2,Q8NRR3">RIPA</z:uniprot> buffer supplemented with <z:uniprot sup="inside" fb="0" ids="P80060">protease inhibitors</z:uniprot> for 30 min, and the whole cell lysates were separated by electrophoresis in sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) and then transferred to PVDF membranes (Millipore, Bedford, MA, USA). </plain></SENT>
<SENT sid="85" pm="."><plain>The membranes were blocked with 5% BSA at room temperature for 2 h before incubation overnight with primary antibodies against the target protein. </plain></SENT>
<SENT sid="86" pm="."><plain>Blots were washed with Tris-buffered saline containing 0.1% Tween 20 three times and then incubated for 2 h with anti-rabbit secondary antibody at room temperature. </plain></SENT>
<SENT sid="87" pm="."><plain>The bands were detected using chemiluminescence detection agents. </plain></SENT>
<SENT sid="88" pm="."><plain>Images were captured with an ImageQuant LAS 4000 digital imaging system (GE Healthcare, Piscataway, NJ). </plain></SENT>
</text></p></sec><sec id="sec2.6"><title><text><SENT sid="89" pm="."><plain>2.6. </plain></SENT>
<SENT sid="90" pm="."><plain>Immunofluorescence Analysis </plain></SENT>
</text></title><p><text><SENT sid="91" pm="."><plain>HUVECs were seeded onto sterile glass coverslips in a 12-well cell culture plate. </plain></SENT>
<SENT sid="92" pm="."><plain>After incubation overnight, the cells were treated with the indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> under <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> stimulation for the indicated time. </plain></SENT>
<SENT sid="93" pm="."><plain>Subsequently, the cells were washed and fixed in 4% paraformaldehyde for 20 min at room temperature and then treated with 0.3% Triton X-100 for 15 min. </plain></SENT>
<SENT sid="94" pm="."><plain>After that, the cells were blocked with 3% BSA for 1 h at room temperature. </plain></SENT>
<SENT sid="95" pm="."><plain>Then, the cells were further incubated with the indicated rabbit primary antibody at 4°C overnight, followed by incubation with a goat anti-rabbit secondary antibody conjugated to Alexa Fluor 488 (for NF-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot>) (1 : 1000, Abcam) or Alexa Fluor 594 (for <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot>) (1 : 1000, Abcam) for 2 h at room temperature. </plain></SENT>
<SENT sid="96" pm="."><plain>The slides were then mounted with one drop of mounting medium that contained DAPI. </plain></SENT>
<SENT sid="97" pm="."><plain>NF-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> were imaged using a confocal microscope. </plain></SENT>
<SENT sid="98" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> was visualized as red and NF-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> was visualized as green, with nuclei as blue. </plain></SENT>
</text></p></sec><sec id="sec2.7"><title><text><SENT sid="99" pm="."><plain>2.7. </plain></SENT>
<SENT sid="100" pm="."><plain>Measurement of Intracellular Reactive Oxygen Species </plain></SENT>
</text></title><p><text><SENT sid="101" pm="."><plain>Intracellular ROS formation was determined with DCFH-DA (KeyGEN, Jiangsu, China). </plain></SENT>
<SENT sid="102" pm="."><plain>HUVECs were seeded in black 96-well plates. </plain></SENT>
<SENT sid="103" pm="."><plain>Subsequently, the cells were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> with or without indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 2 h. </plain></SENT>
<SENT sid="104" pm="."><plain>The cells were then washed with PBS and incubated with 20 μM DCFH-DA for 30 min at 37°C in the dark. </plain></SENT>
<SENT sid="105" pm="."><plain>The fluorescence level was determined using a fluorescence microplate reader at an excitation wavelength of 485 nm and an emission wavelength of 530 nm. </plain></SENT>
</text></p></sec><sec id="sec2.8"><title><text><SENT sid="106" pm="."><plain>2.8. </plain></SENT>
<SENT sid="107" pm="."><plain>F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">Actin</z:uniprot> Staining </plain></SENT>
</text></title><p><text><SENT sid="108" pm="."><plain>Human umbilical vein endothelial cells were cultured and treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> as indicated. </plain></SENT>
<SENT sid="109" pm="."><plain>Then, the cells were fixed with 4% paraformaldehyde at room temperature for 20 min. </plain></SENT>
<SENT sid="110" pm="."><plain>After that, the <z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> cytoskeleton was stained with DyLight 488-phalloidin, and the nuclei were stained with DAPI. </plain></SENT>
<SENT sid="111" pm="."><plain>Stained HUVECs were visualized using a confocal microscope (Olympus FV 10i). </plain></SENT>
</text></p></sec><sec id="sec2.9"><title><text><SENT sid="112" pm="."><plain>2.9. </plain></SENT>
<SENT sid="113" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>Data are expressed as the means ± SD. </plain></SENT>
<SENT sid="115" pm="."><plain>Comparison between different treatments was performed using GraphPad PRISM software version 6.0 using one-way ANOVA with Tukey's post hoc test. </plain></SENT>
<SENT sid="116" pm="."><plain>Statistical significance was set at p values &lt; 0.05. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="sec3"><title><text><SENT sid="117" pm="."><plain>3. </plain></SENT>
<SENT sid="118" pm="."><plain>Results </plain></SENT>
</text></title><sec id="sec3.1"><title><text><SENT sid="119" pm="."><plain>3.1. </plain></SENT>
<SENT sid="120" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the Viability of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-Induced Endothelial Cells </plain></SENT>
</text></title><p><text><SENT sid="121" pm="."><plain>Numerous studies have demonstrated that <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> treatment can impair endothelial cell viability and induce apoptosis. </plain></SENT>
<SENT sid="122" pm="."><plain>First, we evaluated the cytotoxic effects of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> on HUVECs using a <z:uniprot sup="inside" fb="2" ids="O93464">CCK8</z:uniprot> assay. </plain></SENT>
<SENT sid="123" pm="."><plain>All data are expressed as the survival percentage of each group relative to the control group, which is defined as 100%. </plain></SENT>
<SENT sid="124" pm="."><plain>As shown in Figure 1, compared with the control group, <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> at a concentration of 40 ng/mL could markedly suppress the proliferation of HUVECs by nearly 50%. </plain></SENT>
<SENT sid="125" pm="."><plain>In addition, treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> at 5 μg/mL and 10 μg/mL markedly recovered <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-impaired cell viability to about 79.1% and 101.7%, respectively. </plain></SENT>
<SENT sid="126" pm="."><plain>The results also suggested that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> does not influence the viability of HUVECs. </plain></SENT>
</text></p></sec><sec id="sec3.2"><title><text><SENT sid="127" pm="."><plain>3.2. </plain></SENT>
<SENT sid="128" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the Production of Proinflammatory Mediators by Endothelial Cells Stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> </plain></SENT>
</text></title><p><text><SENT sid="129" pm="."><plain>Next, we examined the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on endothelial cell activation stimulated by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="130" pm="."><plain>Endothelial cells stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> produce proinflammatory mediators, including interleukin- (IL-) 6, <z:uniprot sup="inside" fb="0" ids="P79255,P41324,P49113,P46653,P08317,Q102R3,Q9XSX5,O62812,P10145,P67813,P67814,P26894,P19874,P36925,Q7YRB5">IL-8</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">monocyte chemoattractant protein-1</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q4U3U9,P28291,P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">MCP-1</z:uniprot>), which cause more monocytes to be recruited. </plain></SENT>
<SENT sid="131" pm="."><plain>These proinflammatory mediators are reported to aggravate endothelial dysfunction. </plain></SENT>
<SENT sid="132" pm="."><plain>As shown in Figure 2(a), when the cells were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> for 24 h, <z:uniprot sup="inside" fb="0" ids="P79255,P41324,P49113,P46653,P08317,Q102R3,Q9XSX5,O62812,P10145,P67813,P67814,P26894,P19874,P36925,Q7YRB5">IL-8</z:uniprot> production in the supernatant was significantly elevated; however, with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> intervention, <z:uniprot sup="inside" fb="0" ids="P79255,P41324,P49113,P46653,P08317,Q102R3,Q9XSX5,O62812,P10145,P67813,P67814,P26894,P19874,P36925,Q7YRB5">IL-8</z:uniprot> level was markedly and dose-dependently inhibited. </plain></SENT>
<SENT sid="133" pm="."><plain>The same trend of <z:uniprot sup="inside" fb="0" ids="P26892,Q6V919,Q2MH06,Q865W7,P41323,Q28319,P46650,Q90YI0,Q9XT80,P41683,Q95181,P05231,Q865X6,P79341,P51494,Q5I6E3,O35736,P08505,A3FBE9,P41693,Q0GGL7,Q28747,A0S0B0,Q28819,P26893,Q9MZR1,P20607,Q8MKH0,P29455,B6CKP4,Q6L6X6,Q25BC2">IL-6</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q4U3U9,P28291,P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">MCP-1</z:uniprot> was also observed in Figures 2(b) and 2(c). </plain></SENT>
</text></p><p><text><SENT sid="134" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">Macrophage migration inhibitory factor</z:uniprot> (<z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot>) is a key factor mediating the interactions between macrophages and endothelial cells [21]. </plain></SENT>
<SENT sid="135" pm="."><plain>It is considered to interact with other proinflammatory cytokines during inflammation. </plain></SENT>
<SENT sid="136" pm="."><plain>There is evidence showing it is a potent activator of macrophages released by activated endothelial cells. </plain></SENT>
<SENT sid="137" pm="."><plain>The release of <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> by HUVECs was markedly inhibited in response to <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> treatment (Figure 2(d)). </plain></SENT>
</text></p></sec><sec id="sec3.3"><title><text><SENT sid="138" pm="."><plain>3.3. </plain></SENT>
<SENT sid="139" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the Expression of Adhesion Molecules by HUVECs </plain></SENT>
</text></title><p><text><SENT sid="140" pm="."><plain>Accumulated evidence supports a role for adhesion molecules in the progression of atherosclerosis. </plain></SENT>
<SENT sid="141" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> are constitutively expressed on the surface of HUVECs, and <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> is only expressed on the activated endothelium [22]. </plain></SENT>
<SENT sid="142" pm="."><plain>The interaction of <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> and leukocytes mediates the rolling of leukocytes on the activated endothelium, which is the first event in firm adhesion. </plain></SENT>
<SENT sid="143" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> is known to transiently upregulate the expression of adhesion molecules, such as <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot>, in HUVECs [23]. </plain></SENT>
<SENT sid="144" pm="."><plain>We then evaluated the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the expression of adhesion molecules induced by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="145" pm="."><plain>As demonstrated in Figure 3(a), treatment with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) significantly enhanced the expression level of <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> (24 h), <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> (24 h), and <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> (4 h). </plain></SENT>
<SENT sid="146" pm="."><plain>In addition, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> treatment dose-dependently prevented the upregulation of <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> levels by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="147" pm="."><plain>The immunofluorescence staining assay also validated the inhibitory effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (15 μg/mL) on <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> expression levels triggered by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (Figure 3(b)). </plain></SENT>
</text></p></sec><sec id="sec3.4"><title><text><SENT sid="148" pm="."><plain>3.4. </plain></SENT>
<SENT sid="149" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on Monocyte Adhesion to Endothelial Cells </plain></SENT>
</text></title><p><text><SENT sid="150" pm="."><plain>During the initiation of atherosclerosis, endothelial cells are activated and upregulate adhesion molecules and chemokine and cytokine secretion, which is beneficial for monocyte recruitment. </plain></SENT>
<SENT sid="151" pm="."><plain>Due to the significant decrease in cell surface adhesion molecules and proinflammatory mediators in <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>-treated HUVECs, we investigated whether <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> could affect the attachment of immune cells to endothelial cells. </plain></SENT>
<SENT sid="152" pm="."><plain>To evaluate the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 monocyte adhesion to HUVECs in a <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-stimulated proinflammatory environment, HUVECs were seeded and cultured to about 90% confluence and then stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) in the presence or absence of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (15 μg/mL) for 24 h. </plain></SENT>
<SENT sid="153" pm="."><plain>Subsequently, HUVECs were cocultured with prelabeled <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells for 30 min. </plain></SENT>
<SENT sid="154" pm="."><plain>After removal of nonadherent <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells by gentle washing, images were captured under a fluorescence microscope. </plain></SENT>
<SENT sid="155" pm="."><plain>As shown in Figures 4(a) and 4(b), we observed that, compared with the control group, <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> treatment resulted in a 4-fold increase (p &lt; 0.001) in <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 attachment to HUVECs. </plain></SENT>
<SENT sid="156" pm="."><plain>However, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> intervention significantly decreased <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 adhesion to HUVECs (p &lt; 0.01). </plain></SENT>
</text></p></sec><sec id="sec3.5"><title><text><SENT sid="157" pm="."><plain>3.5. </plain></SENT>
<SENT sid="158" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> Suppressed Activation of the NF-κB and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> Pathways in HUVECs </plain></SENT>
</text></title><p><text><SENT sid="159" pm="."><plain>NF-κB is considered as an important regulator of the proinflammatory process and monocyte adhesion. </plain></SENT>
<SENT sid="160" pm="."><plain>To identify the probable molecular mechanism responsible for <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> involvement in the modulation of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-treated HUVECs, we first evaluated the classical NF-κB signaling pathway. </plain></SENT>
<SENT sid="161" pm="."><plain>Here, we show that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> strongly inhibits <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-stimulated HUVECs via two distinct signaling pathways, an NF-κB-dependent pathway and the <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway. </plain></SENT>
</text></p><p><text><SENT sid="162" pm="."><plain>We examined key factors in the NF-κB pathway with western blot. </plain></SENT>
<SENT sid="163" pm="."><plain>Activation of NF-κB required the phosphorylation and degradation of IκB. </plain></SENT>
<SENT sid="164" pm="."><plain>As shown in Figure 5(a), degradation and phosphorylation of IκB were significantly suppressed by the addition of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
<SENT sid="165" pm="."><plain>The effective role of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> to prevent phosphorylation of <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> subunit was also observed. </plain></SENT>
<SENT sid="166" pm="."><plain>In addition, phosphorylated <z:uniprot sup="inside" fb="0" ids="Q95KV1,Q5ZJB4,Q4G3H4,O15111,Q60680,Q6GM53,Q28DZ1">IKKα</z:uniprot>, which is the upstream modulator in the NF-κB pathway, was also inhibited by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
<SENT sid="167" pm="."><plain>To validate this result, immunofluorescence staining was used to determine NF-κB nuclear translocation. </plain></SENT>
<SENT sid="168" pm="."><plain>As shown in Figure 5(b), NF-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> was predominantly located within the cytoplasm in unstimulated cells. </plain></SENT>
<SENT sid="169" pm="."><plain>With <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> treatment, <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> translocated to the nucleus within 30 min. </plain></SENT>
<SENT sid="170" pm="."><plain>However, treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> at 15 μg/mL led to retention of the <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> subunit in the cytoplasm of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-stimulated cells. </plain></SENT>
</text></p><p><text><SENT sid="171" pm="."><plain>We then investigated the role of the <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway in this process. </plain></SENT>
<SENT sid="172" pm="."><plain>The key components of the <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway, <z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot>, <z:uniprot sup="inside" fb="13" ids="P29323">ERK</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot> were evaluated with a western blot. </plain></SENT>
<SENT sid="173" pm="."><plain>As shown in Figure 5(c), treatment of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> resulted in a significant increase of phosphorylation in the <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway. </plain></SENT>
<SENT sid="174" pm="."><plain>The phosphorylation of <z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot> was significantly and concentration-dependently suppressed by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> at 30 min, while the phosphorylation of <z:uniprot sup="inside" fb="13" ids="P29323">ERK</z:uniprot> was not altered. </plain></SENT>
<SENT sid="175" pm="."><plain>The cell lysates obtained at 45 min also validated this result. </plain></SENT>
</text></p></sec><sec id="sec3.6"><title><text><SENT sid="176" pm="."><plain>3.6. </plain></SENT>
<SENT sid="177" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the Activation of <z:uniprot sup="inside" fb="0" ids="O01382">Caspases</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P10417,P49950">Bcl-2</z:uniprot> Expression in HUVECs </plain></SENT>
</text></title><p><text><SENT sid="178" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> has been reported to stimulate apoptosis in HUVECs. </plain></SENT>
<SENT sid="179" pm="."><plain>In addition, the cleavage of <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> is a key step in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced cell death. </plain></SENT>
<SENT sid="180" pm="."><plain>Before activation, <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> exists as an inactive form. </plain></SENT>
<SENT sid="181" pm="."><plain>After <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-treatment, <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> was cleaved to the active form. </plain></SENT>
<SENT sid="182" pm="."><plain>The activation of <z:uniprot sup="inside" fb="0" ids="O01382">caspases</z:uniprot> is considered one mechanism of apoptosis. </plain></SENT>
<SENT sid="183" pm="."><plain>Therefore, we investigated the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the activation of <z:uniprot sup="inside" fb="0" ids="O01382">caspases</z:uniprot>. </plain></SENT>
<SENT sid="184" pm="."><plain>HUVECs were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) for 6 h. </plain></SENT>
<SENT sid="185" pm="."><plain>The expression levels of <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> were examined with western blot. </plain></SENT>
<SENT sid="186" pm="."><plain>Western blot analysis revealed that the expression levels of cleaved <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> significantly increased following <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> treatment, while <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> markedly suppressed this phenomenon. </plain></SENT>
<SENT sid="187" pm="."><plain>Meanwhile, we examined the expression level of <z:uniprot sup="inside" fb="0" ids="P10417,P49950">Bcl-2</z:uniprot>. </plain></SENT>
<SENT sid="188" pm="."><plain>As shown in Figure 6, there was a clear decrease in the expression of <z:uniprot sup="inside" fb="0" ids="P10417,P49950">Bcl-2</z:uniprot> after treatment with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="189" pm="."><plain>These results suggested that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> inhibited the apoptosis of HUVECs stimulated by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
</text></p></sec><sec id="sec3.7"><title><text><SENT sid="190" pm="."><plain>3.7. </plain></SENT>
<SENT sid="191" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> Suppressed <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-Induced ROS Formation in HUVECs </plain></SENT>
</text></title><p><text><SENT sid="192" pm="."><plain>It has been suggested that the enhanced production of intracellular ROS can lead to cell apoptosis. </plain></SENT>
<SENT sid="193" pm="."><plain>To measure the potential modulation of apoptosis and oxidative stress by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>, the production of ROS was evaluated for fluorescence intensity in HUVECs. </plain></SENT>
<SENT sid="194" pm="."><plain>As revealed in Figure 7(a), HUVECs stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> produced an intracellular burst of ROS (about 3.9-fold change). </plain></SENT>
<SENT sid="195" pm="."><plain>The intracellular ROS production in HUVECs was significantly suppressed when treated with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
<SENT sid="196" pm="."><plain>However, the basal level of ROS was not altered by treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> alone. </plain></SENT>
</text></p></sec><sec id="sec3.8"><title><text><SENT sid="197" pm="."><plain>3.8. </plain></SENT>
<SENT sid="198" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> Repressed <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-Induced F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">Actin</z:uniprot> Reorganization in HUVECs </plain></SENT>
</text></title><p><text><SENT sid="199" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> is reported to have the ability to alter the permeability and morphology of endothelial cells. </plain></SENT>
<SENT sid="200" pm="."><plain>To investigate the role of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial function, HUVECs were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) in the presence or absence of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (15 μg/mL) for 24 h. </plain></SENT>
<SENT sid="201" pm="."><plain>Then, the cells were fixed and stained with phalloidin. </plain></SENT>
<SENT sid="202" pm="."><plain>As shown in Figure 8, stimulating HUVECs with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> resulted in a significant increase in the formation of <z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> stress fibers. </plain></SENT>
<SENT sid="203" pm="."><plain>In addition, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> treatment markedly reduced this alteration in HUVECs. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="sec4"><title><text><SENT sid="204" pm="."><plain>4. </plain></SENT>
<SENT sid="205" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="206" pm="."><plain>Atherosclerosis is defined as a chronic inflammatory-fibroproliferative response of the vascular wall to various forms of inflammatory stimuli. </plain></SENT>
<SENT sid="207" pm="."><plain>Disruption of the endothelial cell barrier induced by proinflammatory cytokines, such as <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>, is the initiating step of this disease. </plain></SENT>
</text></p><p><text><SENT sid="208" pm="."><plain>Endothelial cells maintain vascular homeostasis via the secretion of several vasoactive factors, and impairment of barrier integrity leads to the development of vascular inflammatory diseases, such as atherosclerosis. </plain></SENT>
<SENT sid="209" pm="."><plain>As a monolayer in direct contact with the bloodstream, the vascular endothelium is the principal physiological target of the proinflammatory actions of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> and IL-1. </plain></SENT>
<SENT sid="210" pm="."><plain>Extensive evidence has suggested that the endothelium is not simply the inner cellular lining of blood vessels [24]. </plain></SENT>
<SENT sid="211" pm="."><plain>Beyond being passively targeted, endothelial cells are believed to be profoundly involved in this inflammatory process, especially in the regulation of effector cells, such as monocytes and lymphocytes. </plain></SENT>
<SENT sid="212" pm="."><plain>Therefore, the endothelium may act as a therapeutic target due to its critical role in the inflammatory process [25]. </plain></SENT>
</text></p><p><text><SENT sid="213" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">Macrophage migration inhibitory factor</z:uniprot> (<z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot>) is one of the most important cytokines produced by endothelial cells to control the accumulation of effector cells [26]. </plain></SENT>
<SENT sid="214" pm="."><plain>It is recognized as an effective activator of macrophages, participating in the process of recruitment and the accumulation of macrophages at local inflammatory sites. </plain></SENT>
<SENT sid="215" pm="."><plain>As monocyte adhesion to the endothelium is a crucial step in the early stages of atherosclerosis, <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> is considered to be involved in the pathogenesis of atherosclerosis and is closely related to plaque stability [27]. </plain></SENT>
<SENT sid="216" pm="."><plain>Elevated <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> expression was observed in response to some immunostimulants in HUVECs [28]. </plain></SENT>
<SENT sid="217" pm="."><plain>In our experiment, the production of <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> was markedly increased under <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> stimulation in HUVECs, while treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> dose-dependently reduced <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> expression. </plain></SENT>
<SENT sid="218" pm="."><plain>This result was also confirmed by the effect of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> in inhibiting the adhesion of monocytes to endothelial cells. </plain></SENT>
</text></p><p><text><SENT sid="219" pm="."><plain>A prominent feature of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial cell injury is the excess generation of intracellular ROS. </plain></SENT>
<SENT sid="220" pm="."><plain>Moderate levels of ROS have been reported to participate in the physiological functions of cells, while the overproduction of intracellular ROS is closely associated with the progression of atherosclerosis [29, 30]. </plain></SENT>
<SENT sid="221" pm="."><plain>Oxidative stress activates endothelial cells, causing cell injury, apoptosis, and enhanced monocyte adhesion. </plain></SENT>
<SENT sid="222" pm="."><plain>In the present study, treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> attenuated ROS production in HUVECs stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
</text></p><p><text><SENT sid="223" pm="."><plain>The binding of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> to cell surface receptors triggers multiple signaling events, including NF-κB and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway. </plain></SENT>
<SENT sid="224" pm="."><plain>NF-κB has been demonstrated to be a key transcription factor in this signaling pathway. </plain></SENT>
<SENT sid="225" pm="."><plain>Activation of NF-κB is closely associated with the initiation and progression of atherosclerosis. </plain></SENT>
<SENT sid="226" pm="."><plain>In resting cells, NF-κB is maintained in an inactive form within the cytoplasm by the inhibitor of κB (IκB) family but enters the nucleus in response to external stimuli, such as <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="227" pm="."><plain>IκB kinase- (IKK-) dependent phosphorylation and the subsequent ubiquitination and degradation of IκB make NF-κB free to translocate to the nucleus and induce downstream transcription [31]. </plain></SENT>
<SENT sid="228" pm="."><plain>NF-κB has been identified as an important target in the treatment of atherosclerosis. </plain></SENT>
<SENT sid="229" pm="."><plain>Our data revealed that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> markedly reduced the phosphorylation of IκB. </plain></SENT>
<SENT sid="230" pm="."><plain>Additionally, the <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> subunit of NF-κB is constitutively phosphorylated at a low level in unstimulated conditions, and treatment with inflammatory triggers, <z:uniprot sup="inside" fb="107" ids="G8GJ95,G8GJ96,Q947C4,Q50EK2">LPS</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>, for example, results in further phosphorylation. </plain></SENT>
<SENT sid="231" pm="."><plain>The total level of phosphorylation of <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> was also suppressed by the addition of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
</text></p><p><text><SENT sid="232" pm="."><plain>We also investigated the phosphorylation of <z:uniprot sup="inside" fb="0" ids="Q95KV1,Q5ZJB4,Q4G3H4,O15111,Q60680,Q6GM53,Q28DZ1">IKK-α</z:uniprot>/β, which is an upstream signaling molecule of NF-κB. </plain></SENT>
<SENT sid="233" pm="."><plain>The results demonstrated that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> inhibited <z:uniprot sup="inside" fb="0" ids="Q95KV1,Q5ZJB4,Q4G3H4,O15111,Q60680,Q6GM53,Q28DZ1">IKK-α</z:uniprot>/β phosphorylation 30 min after <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> stimulation. </plain></SENT>
<SENT sid="234" pm="."><plain>In addition, the inhibition of ROS generation also contributes to the decrease in NF-κB activation, as NF-κB activation by ROS through the IKK pathway has been suggested [32]. </plain></SENT>
<SENT sid="235" pm="."><plain>The downregulation of cell adhesion molecules in HUVECs by <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> might be mediated through inhibition of the NF-κB pathway, as the <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-mediated increase in <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> expression is mediated through the NF-κB pathway, not the <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway [33]. </plain></SENT>
</text></p><p><text><SENT sid="236" pm="."><plain>Ample evidence has documented intensive crosstalk between the NF-κB and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> signaling pathways. </plain></SENT>
<SENT sid="237" pm="."><plain>The <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway is required for NF-κB activation in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-mediated inflammation [34]. </plain></SENT>
<SENT sid="238" pm="."><plain>In addition, the <z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot> pathway was suggested to promote cell apoptosis [35]. </plain></SENT>
<SENT sid="239" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> was reported to rapidly enter the cells and impact <z:uniprot sup="inside" fb="0" ids="P23799">TLR</z:uniprot> signaling pathway associated with MyD88 and <z:uniprot sup="inside" fb="0" ids="Q4JF29,Q8IUC6">TRIF</z:uniprot> [36]. </plain></SENT>
<SENT sid="240" pm="."><plain>In this case, there is also possibility that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> inhibits <z:uniprot sup="inside" fb="82" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,Q8MKG8,P23383,P79374,Q539C2,Q9BEA1">TNF</z:uniprot> signaling via interaction with the upstream molecules in the signaling pathway. </plain></SENT>
<SENT sid="241" pm="."><plain>Further research needs to be done to elucidate this problem. </plain></SENT>
</text></p><p><text><SENT sid="242" pm="."><plain>Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> is a multifunctional effector molecule involved in a startling range of cellular processes. </plain></SENT>
<SENT sid="243" pm="."><plain>First, as an antimicrobial peptide, <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> exhibits broad antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi, and viruses [37]. </plain></SENT>
<SENT sid="244" pm="."><plain>Second, it was demonstrated to have immunomodulatory effects due to its biphasic effect in the host immune response. </plain></SENT>
<SENT sid="245" pm="."><plain>It can be either proinflammatory or anti-inflammatory, depending on the circumstances [38, 39]. </plain></SENT>
<SENT sid="246" pm="."><plain>In addition, the beneficial effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on wound healing were also reported [40]. </plain></SENT>
<SENT sid="247" pm="."><plain>We previously demonstrated that <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> significantly inhibited the progression of early-stage atherosclerotic lesions, and this effect was correlated with downregulation of macrophage inflammation. </plain></SENT>
<SENT sid="248" pm="."><plain>To date, there is no study focusing on the effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial inflammation. </plain></SENT>
<SENT sid="249" pm="."><plain>In the present study, our data extend the protective effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> to <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial cell injury. </plain></SENT>
</text></p><p><text><SENT sid="250" pm="."><plain>Owing to their strong antimicrobial activity, low molecular weight, and immunogenicity, several researchers and studies are focusing on the clinical use of <z:uniprot sup="inside" fb="0" ids="B3EWR6,O24006">antimicrobial peptides</z:uniprot> as a new class of antibiotics [41], and some of them are already in the clinical development stage [42]. </plain></SENT>
<SENT sid="251" pm="."><plain>However, <z:uniprot sup="inside" fb="0" ids="P86385">β-defensins</z:uniprot> had limited success in clinical application. </plain></SENT>
<SENT sid="252" pm="."><plain>The reasons include the high synthesis cost and short half-lives in blood. </plain></SENT>
<SENT sid="253" pm="."><plain>Cationic peptides are not stable in the serum due to high susceptibility to enzymatic degradation. </plain></SENT>
<SENT sid="254" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> was observed to be completely digested in contact with simulated gastric fluid [43]. </plain></SENT>
<SENT sid="255" pm="."><plain>One solution to the limitations is gene delivery of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
<SENT sid="256" pm="."><plain>Another way is to develop a structurally modified peptide of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> with certain biological activity. </plain></SENT>
<SENT sid="257" pm="."><plain>Notable examples include a C-terminus peptide and a linear <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> peptide with anti-inflammatory and antifungal activities [44–46]. </plain></SENT>
<SENT sid="258" pm="."><plain>This may provide new therapeutic approaches to harness the pharmaceutical potential of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
</text></p><p><text><SENT sid="259" pm="."><plain>However, the endothelial cells we used in this study were obtained from the human umbilical vein, not aortas, which are the main location forming atherosclerotic plaques. </plain></SENT>
<SENT sid="260" pm="."><plain>The difference in physiology and shear stress between veins and arteries might contribute to heterogeneity between ECs in veins and aortas [47–49]. </plain></SENT>
<SENT sid="261" pm="."><plain>In addition, some differences in the immune response to proinflammatory cytokines, such as <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>, might exist. </plain></SENT>
<SENT sid="262" pm="."><plain>Further confirmation in animal models should be performed to uncover the underlying molecular mechanisms. </plain></SENT>
<SENT sid="263" pm="."><plain>In addition, cell density was identified to have an impact on the immune response of HUVECs [50]. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec id="sec5"><title><text><SENT sid="264" pm="."><plain>5. </plain></SENT>
<SENT sid="265" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><text><SENT sid="266" pm="."><plain>In summary, the results of this study demonstrate that <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial cell activation can be reversed by treatment with <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot>. </plain></SENT>
<SENT sid="267" pm="."><plain>Furthermore, the anti-inflammatory effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-treated HUVECs seem to be closely related to downregulation of NF-κB pathway and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> pathway. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="268" pm="."><plain>This work was supported by the National Natural Science Foundation of China (no. 81371152). </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="COMP_INT"><sec sec-type="COI-statement"><title>Competing Interests</title><p>The authors have no conflict of interests to declare.</p></sec></SecTag><SecTag type="REF"><ref-list><ref id="B1"><text><SENT sid="269" pm="."><plain>1RiceJ. </plain></SENT>
<SENT sid="270" pm="."><plain>B.StollL. </plain></SENT>
<SENT sid="271" pm="."><plain>L.LiW. </plain></SENT>
<SENT sid="272" pm="."><plain>G.Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statinsArteriosclerosis, Thrombosis, and Vascular Biology200323915761582 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="273" pm="."><plain>2RamjiD. </plain></SENT>
<SENT sid="274" pm="."><plain>P.DaviesT. </plain></SENT>
<SENT sid="275" pm="."><plain>S.Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targetsCytokine and <z:uniprot sup="inside" fb="0" ids="Q8V307,Q776B5,P08072,Q6RZT5,P08441">Growth Factor</z:uniprot> Reviews201526667368510.1016/j.cytogfr.2015.04.0032-s2.0-8494910801326005197 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="276" pm="."><plain>3LandmesserU.HornigB.DrexlerH.Endothelial function: a critical determinant in atherosclerosis?Circulation200410921, supplement 1II27II3310.1161/01.cir.0000115644.35804.8b2-s2.0-264255624415173060 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="277" pm="."><plain>4PoberJ. </plain></SENT>
<SENT sid="278" pm="."><plain>S.SessaW. </plain></SENT>
<SENT sid="279" pm="."><plain>C.Evolving functions of endothelial cells in inflammationNature Reviews Immunology200771080381510.1038/nri21712-s2.0-34748914299 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="280" pm="."><plain>5LaiT.ChungC.ChenB.Gold nanoparticles compromise <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced endothelial cell adhesion molecule expression through NF-κB and protein degradation pathways and reduce neointima formation in a rat carotid balloon injury modelJournal of Biomedical Nanotechnology201612122185220110.1166/jbn.2016.2315 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="281" pm="."><plain>6BianT.LiL.LyuJ.CuiD.LeiL.YanF.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of <z:uniprot sup="inside" fb="0" ids="P0DSE0,P0DMT6,P0DKW5,P0DTT1,P0DKW6,P0DML7,P0DN41,Q03247,P0DOC3,P18649,P0DN38,P23529,P0DOA3,A0A0D9S1R0,P0DKU9,P0DTT2,Q9GLM8,P02649,Q9GLM6,P0DML8,P10517,Q28502,P0DO94,P08226,A0A2Y9GHM3,P0DML9,P0DN39,Q9GJU3,P05770,P0DKY2,P0DMM0,P18650,P0DKW7,Q9GLM7,P18287,P02650,P0DO95,P0DKW8,Q28995,Q7M2U8,P0DTR8,Q9GLC0,P0DMM1,Q7M2U7">ApoE</z:uniprot>-deficient micePeptides2016829210010.1016/j.peptides.2016.06.0022-s2.0-8497523039927298203 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="282" pm="."><plain>7HaddyN.SassC.DroeschS.<z:uniprot sup="inside" fb="0" ids="P26892,Q6V919,Q2MH06,Q865W7,P41323,Q28319,P46650,Q90YI0,Q9XT80,P41683,Q95181,P05231,Q865X6,P79341,P51494,Q5I6E3,O35736,P08505,A3FBE9,P41693,Q0GGL7,Q28747,A0S0B0,Q28819,P26893,Q9MZR1,P20607,Q8MKH0,P29455,B6CKP4,Q6L6X6,Q25BC2">IL-6</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohortAtherosclerosis2003170227728310.1016/s0021-9150(03)00287-92-s2.0-024266139914612208 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="283" pm="."><plain>8ChenG.GoeddelD. </plain></SENT>
<SENT sid="284" pm="."><plain>V.<z:uniprot sup="inside" fb="0" ids="O19131,P19438,P25118,P50555,P22934">TNF-R1</z:uniprot> signaling: a beautiful pathwayScience200229655731634163510.1126/science.10719242-s2.0-003720494812040173 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="285" pm="."><plain>9Wójciak-StothardB.EntwistleA.GargR.RidleyA. </plain></SENT>
<SENT sid="286" pm="."><plain>J.Regulation of <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced reorganization of the <z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> cytoskeleton and cell-cell junctions by Rho, Rac, and <z:uniprot sup="inside" fb="0" ids="Q16YG0,Q17031,P40793,Q29HY3,P60766,Q8CFN2">Cdc42</z:uniprot> in human endothelial cellsJournal of Cellular Physiology1998176115016510.1002/(sici)1097-4652(199807)176:1&lt;150::aid-jcp17&gt;3.0.co;2-b2-s2.0-26426157529618155 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="287" pm="."><plain>10McKenzieJ. </plain></SENT>
<SENT sid="288" pm="."><plain>A. </plain></SENT>
<SENT sid="289" pm="."><plain>G.RidleyA. </plain></SENT>
<SENT sid="290" pm="."><plain>J.Roles of Rho/ROCK and <z:uniprot sup="inside" fb="0" ids="Q32MK0,Q28824,P11799,Q15746,Q6PDN3,P79280,P29294,O02827">MLCK</z:uniprot> in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced changes in endothelial morphology and permeabilityJournal of Cellular Physiology2007213122122810.1002/jcp.211142-s2.0-3454847810017476691 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="291" pm="."><plain>11HaynesR. </plain></SENT>
<SENT sid="292" pm="."><plain>J.McElveenJ. </plain></SENT>
<SENT sid="293" pm="."><plain>E.DuaH. </plain></SENT>
<SENT sid="294" pm="."><plain>S.TigheP. </plain></SENT>
<SENT sid="295" pm="."><plain>J.LiversidgeJ.Expression of human <z:uniprot sup="inside" fb="0" ids="P86385">beta-defensins</z:uniprot> in intraocular tissuesInvestigative Ophthalmology and Visual Science20004110302630312-s2.0-003383198610967060 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="296" pm="."><plain>12BergmanP.JohanssonL.WanH.Induction of the antimicrobial peptide <z:uniprot sup="inside" fb="143" ids="U5KJJ1,U5KJM6,U5KJC9,U5KJT7,U5KJJ0,U5KJM4,U5KJZ2">CRAMP</z:uniprot> in the blood-brain barrier and meninges after meningococcal infectionInfection and Immunity200674126982699110.1128/IAI.01043-062-s2.0-3384548730117030578 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="297" pm="."><plain>13KawsarH. </plain></SENT>
<SENT sid="298" pm="."><plain>I.GhoshS. </plain></SENT>
<SENT sid="299" pm="."><plain>K.HirschS. </plain></SENT>
<SENT sid="300" pm="."><plain>A.KoonH. </plain></SENT>
<SENT sid="301" pm="."><plain>B.WeinbergA.JinG.Expression of human <z:uniprot sup="inside" fb="0" ids="P46160,P85150,P82020,O19039,O15263,Q9BDS9,Q9TT12,P46158,P85113">β-defensin-2</z:uniprot> in intratumoral vascular endothelium and in endothelial cells induced by transforming <z:uniprot sup="inside" fb="0" ids="Q8V307,Q776B5,P08072,Q6RZT5,P08441">growth factor</z:uniprot> βPeptides201031219520110.1016/j.peptides.2009.12.0082-s2.0-7394912215220006664 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="302" pm="."><plain>14BaroniA.DonnarummaG.PaolettiI.Antimicrobial human <z:uniprot sup="inside" fb="0" ids="P46160,P85150,P82020,O19039,O15263,Q9BDS9,Q9TT12,P46158,P85113">beta-defensin-2</z:uniprot> stimulates migration, proliferation and tube formation of human umbilical vein endothelial cellsPeptides200930226727210.1016/j.peptides.2008.11.0012-s2.0-5814952686519041917 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="303" pm="."><plain>15BurgeyC.KernW. </plain></SENT>
<SENT sid="304" pm="."><plain>V.RömerW.SakincT.RiegS.The innate defense <z:uniprot sup="inside" fb="0" ids="B3EWR6,O24006">antimicrobial peptides</z:uniprot> <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q9H1E1">RNase7</z:uniprot> are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokinesMicrobes and Infection201517535335910.1016/j.micinf.2015.01.0052-s2.0-8493899773325637949 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="305" pm="."><plain>16LiL.BianT.LyuJ.CuiD.LeiL.YanF.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin-3</z:uniprot> alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharideInternational Immunopharmacology20163820421310.1016/j.intimp.2016.06.0032-s2.0-8497390243027289299 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="306" pm="."><plain>17LyuJ.BianT.ChenB. <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharideCytokine201792485410.1016/j.cyto.2016.12.01528092794 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="307" pm="."><plain>18KoflerS.NickelT.WeisM.Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammationClinical Science2005108320521310.1042/cs200401742-s2.0-1484430328115540988 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="308" pm="."><plain>19GerhardtT.LeyK.Monocyte trafficking across the vessel wallCardiovascular Research2015107332133010.1093/cvr/cvv1472-s2.0-8493852745425990461 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="309" pm="."><plain>20SwirskiF. </plain></SENT>
<SENT sid="310" pm="."><plain>K.LibbyP.AikawaE.Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJournal of Clinical Investigation2007117119520510.1172/jci299502-s2.0-3384597019217200719 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="311" pm="."><plain>21ChengQ.McKeownS. </plain></SENT>
<SENT sid="312" pm="."><plain>J.SantosL.<z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">Macrophage migration inhibitory factor</z:uniprot> increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion moleculesJournal of Immunology201018521238124710.4049/jimmunol.09041042-s2.0-77955483187 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="313" pm="."><plain>22JubeliE.MoineL.Vergnaud-GauduchonJ.BarrattG.<z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> as a target for drug delivery and molecular imagingJournal of Controlled Release2012158219420610.1016/j.jconrel.2011.09.0842-s2.0-8485870313021983284 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="314" pm="."><plain>23MinJ.-K.KimY.-M.KimS. </plain></SENT>
<SENT sid="315" pm="."><plain>W.<z:uniprot sup="inside" fb="0" ids="O14788,O35235,Q9ESE2">TNF-related activation-induced cytokine</z:uniprot> enhances leukocyte adhesiveness: induction of <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> via <z:uniprot sup="inside" fb="82" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,Q8MKG8,P23383,P79374,Q539C2,Q9BEA1">TNF</z:uniprot> receptor-associated factor and <z:uniprot sup="inside" fb="0" ids="Q25378,P13678">protein kinase C</z:uniprot>-dependent NF-κB activation in endothelial cellsJournal of Immunology2005175153154010.4049/jimmunol.175.1.5312-s2.0-21244499298 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="316" pm="."><plain>24CinesD. </plain></SENT>
<SENT sid="317" pm="."><plain>B.PollakE. </plain></SENT>
<SENT sid="318" pm="."><plain>S.BuckC. </plain></SENT>
<SENT sid="319" pm="."><plain>A.Endothelial cells in physiology and in the pathophysiology of vascular disordersBlood19989110352735612-s2.0-00325252079572988 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="320" pm="."><plain>25MasonJ. </plain></SENT>
<SENT sid="321" pm="."><plain>C.Cytoprotective pathways in the vascular endothelium. </plain></SENT>
<SENT sid="322" pm="."><plain>Do they represent a viable therapeutic target?Vascular Pharmacology201610.1016/j.<z:uniprot sup="inside" fb="0" ids="P18623">vph</z:uniprot>.2016.08.0022-s2.0-84981718421 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="323" pm="."><plain>26LinS.-G.YuX.-Y.ChenY.-X.De novo expression of <z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">macrophage migration inhibitory factor</z:uniprot> in atherogenesis in rabbitsCirculation Research200087121202120810.1161/01.RES.87.12.12022-s2.0-003462380211110779 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="324" pm="."><plain>27SchmeisserA.MarquetantR.IllmerT.The expression of <z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">macrophage migration inhibitory factor</z:uniprot> 1α (<z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> 1α) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instabilityAtherosclerosis20051781839410.1016/j.atherosclerosis.2004.08.0382-s2.0-1004422609415585204 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="325" pm="."><plain>28Burger-KentischerA.GoebelH.SeilerR.Expression of <z:uniprot sup="inside" fb="0" ids="P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7">macrophage migration inhibitory factor</z:uniprot> in different stages of human atherosclerosisCirculation2002105131561156610.1161/01.cir.0000012942.49244.822-s2.0-003700713711927523 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="326" pm="."><plain>29KanetoH.KatakamiN.MatsuhisaM.MatsuokaT.-A.Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosisMediators of Inflammation201020101145389210.1155/2010/4538922-s2.0-77952480033 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="327" pm="."><plain>30TaniyamaY.GriendlingK. </plain></SENT>
<SENT sid="328" pm="."><plain>K.Reactive oxygen species in the vasculature: molecular and cellular mechanismsHypertension20034261075108110.1161/01.hyp.0000100443.09293.4f2-s2.0-034810942514581295 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="329" pm="."><plain>31LiC.-C. </plain></SENT>
<SENT sid="330" pm="."><plain>H.KornerM.FerrisD. </plain></SENT>
<SENT sid="331" pm="."><plain>K.ChenE.DaiR.-M.LongoD. </plain></SENT>
<SENT sid="332" pm="."><plain>L.NF-κB/Rel family members are physically associated phosphoproteinsBiochemical Journal1994303249950610.1042/bj30304992-s2.0-00281510807980409 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="333" pm="."><plain>32GloireG.Legrand-PoelsS.PietteJ.NF-κB activation by reactive oxygen species: fifteen years laterBiochemical Pharmacology200672111493150510.1016/j.<z:uniprot sup="inside" fb="88" ids="P19567,Q796Y8,Q9ZHF0,Q83CY8,P0AE54,P0AE53,P0AE52,P44411,Q9ZMU4,P55979,P9WIE0,P9WIE1,P0AE55,Q8P9V9">bcp</z:uniprot>.2006.04.0112-s2.0-3375052363216723122 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="334" pm="."><plain>33ZhouZ.ConnellM. </plain></SENT>
<SENT sid="335" pm="."><plain>C.MacEwanD. </plain></SENT>
<SENT sid="336" pm="."><plain>J.<z:uniprot sup="inside" fb="0" ids="O19131,P19438,P25118,P50555,P22934">TNFR1</z:uniprot>-induced NF-κB, but not <z:uniprot sup="inside" fb="13" ids="P29323">ERK</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="O62618">p38MAPK</z:uniprot> or <z:uniprot sup="inside" fb="0" ids="P92208,Q966Y3">JNK</z:uniprot> activation, mediates <z:uniprot sup="inside" fb="82" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,Q8MKG8,P23383,P79374,Q539C2,Q9BEA1">TNF</z:uniprot>-induced <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> expression on endothelial cellsCellular Signalling20071961238124810.1016/j.cellsig.2006.12.0132-s2.0-3414709956017292586 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="337" pm="."><plain>34BergheW. </plain></SENT>
<SENT sid="338" pm="."><plain>V.PlaisanceS.BooneE.<z:uniprot sup="inside" fb="11" ids="O95433,O97628,Q9Q6X7,P04383,P06663,Q04929,P46108,Q64010,Q63768,P82869,P0C796,P0C797,Q9Y2S7,Q9NV58">p38</z:uniprot> and extracellular signal-regulated kinase <z:uniprot sup="inside" fb="0" ids="Q00859">mitogen-activated protein kinase</z:uniprot> pathways are required for nuclear factor-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> transactivation mediated by tumor necrosis factorJournal of Biological Chemistry199827363285329010.1074/jbc.273.6.32852-s2.0-00324888379452444 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="339" pm="."><plain>35NakanoH.NakajimaA.Sakon-KomazawaS.PiaoJ.-H.XueX.OkumuraK.Reactive oxygen species mediate crosstalk between NF-κB and JNKCell Death and Differentiation200613573073710.1038/sj.<z:uniprot sup="inside" fb="8" ids="A3N1Z1,B3GYC3,B0BQT2,A6VLF5,A0KJH4,A4SNI2,Q5E4R6,B5FEN2,Q9KD53,P19079,A8AE87,A7MLJ4,A7ZNW5,B7UFF9,B7MF55,B7LA09,Q8X648,B5YW75,B7NMA8,B7MXF5,B7M4Y8,C4ZSM3,B1X7N2,A8A204,A1AD04,Q0TFU8,Q8FFV3,B1IYC6,P0ABF6,B7NCH2,B6I8J3,B1LKP0,Q1R9T0,C5BCM4,A4WCI1,B2VIF3,B7LVA3,Q7VMJ6,Q4QK60,A5UBV9,A5UEI7,P44325,Q0I4X6,B0USP2,B5XP65,A6TBN1,Q65RG8,P47298,P47718,P75051,P9WPH2,P9WPH3,Q9CP11,Q6D3B4,C6DDS7,Q7N6K3,Q6LRI0,B4ESY3,Q3IBX5,B5EYN3,A9MKS5,Q57MF5,B5FMZ9,B5R153,B5RC22,B4TAK5,B4SY15,Q5PE68,A9N6L3,C0Q0V4,B5BE52,B4TNP0,Q8Z5A8,Q8ZNM0,A8GC32,A1S723,B8EF35,A3D392,A6WLY5,A9KXF0,Q083S7,B0TQV3,A3QDC9,Q8EDG1,A8H5H1,A4Y5R0,B8CR83,A0KYD1,A8FWK2,Q0HHI5,Q0HTT9,A1RL10,B1KRC5,B2TVV2,Q322V3,Q32EM3,Q0T2Y0,P0ABF7,Q3Z062,Q2NUD2,Q9S3M0,A5F1V7,A7MVH6,Q9KSM5,C3LLS7,Q87Q52,B7VPF1,Q8DA31,Q7MK48,A7FJK3,Q1C9U7,B2JZJ6,Q8ZG08,A9R1B9,Q1CGT5,A4TKN7,Q66C79,B1JPZ5">cdd</z:uniprot>.44018302-s2.0-3364596561616341124 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="340" pm="."><plain>36SempleF.MacphersonH.WebbS.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> affects the activity of pro-inflammatory pathways associated with MyD88 and TRIFEuropean Journal of Immunology201141113291330010.1002/eji.2011416482-s2.0-8005492079121809339 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="341" pm="."><plain>37GursoyU. </plain></SENT>
<SENT sid="342" pm="."><plain>K.KönönenE.Understanding the roles of gingival beta-defensinsJournal of Oral Microbiology2012411512710.3402/jom.v4i0.151272-s2.0-84864797071 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="343" pm="."><plain>38SempleF.WebbS.LiH. </plain></SENT>
<SENT sid="344" pm="."><plain>N.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> has immunosuppressive activity in vitro and in vivoEuropean Journal of Immunology20104041073107810.1002/eji.20094004120104491 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="345" pm="."><plain>39FunderburgN.LedermanM. </plain></SENT>
<SENT sid="346" pm="."><plain>M.FengZ.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin-3</z:uniprot> activates professional antigen-presenting cells via <z:uniprot sup="inside" fb="0" ids="Q15399,Q9EPQ1">Toll-like receptors 1</z:uniprot> and 2Proceedings of the National Academy of Sciences of the United States of America200710447186311863510.1073/PNAS.07021301042-s2.0-3674904267118006661 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="347" pm="."><plain>40ShengQ.LvZ.CaiW.Human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin-3</z:uniprot> promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat modelPediatric Research201476326927910.1038/pr.2014.932-s2.0-8490735128724956228 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="348" pm="."><plain>41BomanH. </plain></SENT>
<SENT sid="349" pm="."><plain>G.Peptide antibiotics and their role in innate immunityAnnual Review of Immunology199513619210.1146/annurev.iy.13.040195.0004252-s2.0-0028933794 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="350" pm="."><plain>42JarczakJ.KościuczukE. </plain></SENT>
<SENT sid="351" pm="."><plain>M.LisowskiP.<z:uniprot sup="inside" fb="0" ids="Q86QN6,Q86QI5,P85213,P80154,Q17027,P81462,C0HJX7,P36192,B2D2C0,O96049,P80407,P83404,P37364,Q86LE4,Q10745,Q5BU36,Q8WQZ3">Defensins</z:uniprot>: natural component of human innate immunityHuman Immunology20137491069107910.1016/j.humimm.2013.05.0082-s2.0-8488096450823756165 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="352" pm="."><plain>43ChenX.YangY.ShiZ.GaoM.-Q.ZhangY.Effects of genetically modified milk containing human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">beta-defensin-3</z:uniprot> on gastrointestinal health of micePLoS ONE2016117e015970010.1371/journal.pone.01597002-s2.0-84979554544 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="353" pm="."><plain>44TheryT.TharappelJ. </plain></SENT>
<SENT sid="354" pm="."><plain>C.KraszewskaJ.BeckettM.BondU.ArendtE. </plain></SENT>
<SENT sid="355" pm="."><plain>K.Antifungal activity of a synthetic human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot> and potential applications in cereal-based productsInnovative Food Science &amp; Emerging Technologies20163816016810.1016/j.ifset.2016.09.018 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="356" pm="."><plain>45LimS.AhnK.KimC.Antifungal effects of synthetic human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">β-defensin 3</z:uniprot>-C15 peptideRestorative Dentistry &amp; Endodontics2016412p. </plain></SENT>
<SENT sid="357" pm="."><plain>9110.5395/rde.2016.41.2.9127200276 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="358" pm="."><plain>46LeeJ. </plain></SENT>
<SENT sid="359" pm="."><plain>Y.SuhJ. </plain></SENT>
<SENT sid="360" pm="."><plain>S.KimJ. </plain></SENT>
<SENT sid="361" pm="."><plain>M.Identification of a cell-penetrating peptide domain from human <z:uniprot sup="inside" fb="0" ids="P81534,Q95JD2,P46161,Q9WTL0,Q32ZI4,Q9DG58">beta-defensin 3</z:uniprot> and characterization of its anti-inflammatory activityInternational Journal of Nanomedicine2015105423543410.2147/IJN.S900142-s2.0-8494005479126347021 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="362" pm="."><plain>47AirdW. </plain></SENT>
<SENT sid="363" pm="."><plain>C.Phenotypic heterogeneity of the endothelium: I. </plain></SENT>
<SENT sid="364" pm="."><plain>Structure, function, and mechanismsCirculation Research2007100215817310.1161/01.RES.0000255691.76142.4a2-s2.0-3384679810617272818 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="365" pm="."><plain>48TopperJ. </plain></SENT>
<SENT sid="366" pm="."><plain>N.GimbroneM. </plain></SENT>
<SENT sid="367" pm="."><plain>A.Jr.Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotypeMolecular Medicine Today199951404610.1016/s1357-4310(98)01372-02-s2.0-003261307110088131 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="368" pm="."><plain>49ChistiakovD. </plain></SENT>
<SENT sid="369" pm="."><plain>A.OrekhovA. </plain></SENT>
<SENT sid="370" pm="."><plain>N.BobryshevY. </plain></SENT>
<SENT sid="371" pm="."><plain>V.Effects of shear stress on endothelial cells: go with the flowActa Physiologica2016219238240810.1111/apha.127252-s2.0-8497821540627246807 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="372" pm="."><plain>50HamadaK.OsakaM.YoshidaM.Cell density impacts epigenetic regulation of cytokine-induced <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> gene expression in vascular endotheliumPLoS ONE201494e9050210.1371/journal.pone.00905022-s2.0-84898855074 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="373" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced cell death. </plain></SENT>
<SENT sid="374" pm="."><plain>HUVECs were treated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) and various concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h. </plain></SENT>
<SENT sid="375" pm="."><plain>The cell viability of HUVECs was determined with a <z:uniprot sup="inside" fb="2" ids="O93464">CCK8</z:uniprot> assay according to the instructions of manufacturers. </plain></SENT>
<SENT sid="376" pm="."><plain>Data are presented as the survival rate compared to the control group, which is defined as 100%. </plain></SENT>
<SENT sid="377" pm="."><plain>Values represent the means ± SD (n = 6). ###p &lt; 0.001 compared with the control group. ∗∗p &lt; 0.01, ∗∗∗p &lt; 0.001 compared with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> group. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.001"/></fig></SecTag><SecTag type="FIG"><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="378" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P79255,P41324,P49113,P46653,P08317,Q102R3,Q9XSX5,O62812,P10145,P67813,P67814,P26894,P19874,P36925,Q7YRB5">IL-8</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P26892,Q6V919,Q2MH06,Q865W7,P41323,Q28319,P46650,Q90YI0,Q9XT80,P41683,Q95181,P05231,Q865X6,P79341,P51494,Q5I6E3,O35736,P08505,A3FBE9,P41693,Q0GGL7,Q28747,A0S0B0,Q28819,P26893,Q9MZR1,P20607,Q8MKH0,P29455,B6CKP4,Q6L6X6,Q25BC2">IL-6</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="Q4U3U9,P28291,P52203,Q08782,Q9TTQ3,P13500,P61274,P61275,P10148,P42831,P28292,P14844">MCP-1</z:uniprot>, and <z:uniprot sup="inside" fb="2" ids="P91850,P81529,P81748,O44786,P80177,Q02960,P14174,Q4R549,Q6DN04,O55052,P34884,P80928,P30904,Q1ZZU7,Q76BK2,A9JSE7,P03971">MIF</z:uniprot> production in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-stimulated HUVECs. </plain></SENT>
<SENT sid="379" pm="."><plain>Cells were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) with or without various concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h. </plain></SENT>
<SENT sid="380" pm="."><plain>Then, the culture supernatants were collected by centrifugation and analyzed by ELISA according to the manufacturer's instructions. </plain></SENT>
<SENT sid="381" pm="."><plain>Data are expressed as the mean ± SD (n = 6). ###p &lt; 0.001 compared with the control group. ∗p &lt; 0.05, ∗∗p &lt; 0.01, and ∗∗∗p &lt; 0.001 compared with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> group. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.002"/></fig></SecTag><SecTag type="FIG"><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p><text><SENT sid="382" pm="."><plain>The effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on the expression of adhesion molecules in <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-activated HUVECs. </plain></SENT>
<SENT sid="383" pm="."><plain>(a) HUVECs were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) with or without the indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h (<z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot> analysis) or 4 h (<z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot> analysis). </plain></SENT>
<SENT sid="384" pm="."><plain>Whole cell lysates were extracted and analyzed by western blot using antibodies specific to <z:uniprot sup="inside" fb="0" ids="Q28260,P19320,P29533,P29534">VCAM-1</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P98107,P33730,Q95LG1,P16581,Q00690,P98110,P27113,P98105">E-selectin</z:uniprot>. </plain></SENT>
<SENT sid="385" pm="."><plain>(b) Immunofluorescence analysis for <z:uniprot sup="inside" fb="0" ids="Q95132,P33729,Q5NKV9,P05362,Q5NKV6,P13597,Q5NKV4,Q28806,Q00238">ICAM-1</z:uniprot> expression was conducted as mentioned above, and images were obtained using a fluorescence microscope (original magnification: 400x, scale bar 50 μm). </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.003"/></fig></SecTag><SecTag type="FIG"><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p><text><SENT sid="386" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced adhesion to <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells in HUVECs. </plain></SENT>
<SENT sid="387" pm="."><plain>HUVECs were stimulated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) and the indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 24 h. </plain></SENT>
<SENT sid="388" pm="."><plain>After stimulation, HUVECs were cocultured with calcein-AM-labeled <z:uniprot sup="inside" fb="0" ids="P10070,P48733,Q862Z3,P07911,Q91X17,P27590">THP</z:uniprot>-1 cells for 30 min. </plain></SENT>
<SENT sid="389" pm="."><plain>(a) Images were captured using a fluorescence microscope (original magnification: 100x). </plain></SENT>
<SENT sid="390" pm="."><plain>(b) Adherent cells were measured using a microplate reader at excitation and emission wavelengths of 490 nm and 515 nm, respectively. </plain></SENT>
<SENT sid="391" pm="."><plain>The results were expressed as the mean ± SD, n = 3. ###p &lt; 0.001 compared with the control group. ∗∗p &lt; 0.01 compared with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> group. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.004"/></fig></SecTag><SecTag type="FIG"><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p><text><SENT sid="392" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced NF-κB and <z:uniprot sup="inside" fb="0" ids="O42781,Q00859,P27638">MAPK</z:uniprot> activation in HUVECs. </plain></SENT>
<SENT sid="393" pm="."><plain>(a) HUVECs were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) with or without the indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 30 min. </plain></SENT>
<SENT sid="394" pm="."><plain>Whole cell lysates were centrifuged and analyzed with western blot using specific antibodies. </plain></SENT>
<SENT sid="395" pm="."><plain>(b) Immunofluorescence analysis for NF-κB <z:uniprot sup="inside" fb="2" ids="E1QC64,P0CJ81,P41823,P21521,P48018,P47191,P21579,P46096,P21707,Q9H4A3">p65</z:uniprot> localization was conducted as mentioned above, and images were captured using a confocal laser scanning microscope system (Nikon A1, Japan) (original magnification: 400x, scale bar 50 μm). </plain></SENT>
<SENT sid="396" pm="."><plain>(c) HUVECs were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) with or without the indicated concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 30 min and 45 min. </plain></SENT>
<SENT sid="397" pm="."><plain>Whole cell lysates were centrifuged and analyzed with western blot using specific antibodies. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.005"/></fig></SecTag><SecTag type="FIG"><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p><text><SENT sid="398" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> inhibits HUVEC apoptosis stimulated by <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>. </plain></SENT>
<SENT sid="399" pm="."><plain>After incubation with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) and different concentrations of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> for 6 h, the protein levels of cleaved <z:uniprot sup="inside" fb="0" ids="Q08DY9,Q8MKI5,Q8MJU1,P42574,Q2PFV2,Q60431,P70677,Q5IS54,Q95ND5,Q8MJC3,P55213,Q5IS99,P55866">caspase-3</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q9Y702,Q0PGG4,P60712,P84336,O18840,Q71FK5,P60706,Q76N69,P84856,P48975,P83751,P83750,P60708,P60709,Q4R561,Q711N9,P60710,P68143,P79818,Q5R1X3,Q6QAQ1,Q5R6G0,P29751,P60711,O42161,P60713,Q91ZK5,Q4L0Y2,P60707,P15475,O93400,Q6NVA9">β-actin</z:uniprot> in HUVECs were detected with an immunoblot assay. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.006"/></fig></SecTag><SecTag type="FIG"><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p><text><SENT sid="400" pm="."><plain>Inhibitory effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced ROS formation in HUVECs. </plain></SENT>
<SENT sid="401" pm="."><plain>HUVECs were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) and <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (15 μg/mL) for 2 h. </plain></SENT>
<SENT sid="402" pm="."><plain>Intracellular ROS accumulation was determined by observation under a fluorescence microscope (a) or fluorescence measurement with a microplate reader (b) after incubation with the ROS detector DCFH-DA for 30 min (original magnification: 400x). </plain></SENT>
<SENT sid="403" pm="."><plain>Values represent the mean ± SD. ###p &lt; 0.001 compared with the control group; ∗∗∗p &lt; 0.001 compared with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> alone. </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.007"/></fig></SecTag><SecTag type="FIG"><fig id="fig8" orientation="portrait" position="float"><label>Figure 8</label><caption><p><text><SENT sid="404" pm="."><plain>Effects of <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot>-induced F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> rearrangement. </plain></SENT>
<SENT sid="405" pm="."><plain>HUVECs were incubated with <z:uniprot sup="inside" fb="0" ids="P59684,Q1G1A2,Q06599,P59693,Q2MH05,Q19LH4,Q75N23,P51742,P13296,P51435,P51743,Q1WM27,Q8WNR1,P19101,P29553,P01375,P59694,O77764,P79337,P48094,O35734,P06804,Q8HZD9,P59695,O77510,P33620,P36939,P23563,P04924,P16599,Q8MKG8,P23383,Q8JFG3,P79374,Q539C2,Q9BEA1">TNF-α</z:uniprot> (40 ng/mL) with or without <z:uniprot sup="inside" fb="0" ids="P81534">hBD3</z:uniprot> (15 μg/mL) for 24 h. </plain></SENT>
<SENT sid="406" pm="."><plain>After that, cells were washed with PBS. </plain></SENT>
<SENT sid="407" pm="."><plain>F-<z:uniprot sup="inside" fb="72" ids="Q05214,P53491,P26182,P53455,Q75D00,Q2U7A3,O13419,P90689,Q92192,P14235,Q9UVZ8,P60009,P80709,P53498,P53499,O65315,Q9UVX4,P30161,O17320,Q92193,P48465,P26183,P53500,Q24733,Q8SWN8,P11426,Q8X119,P53502,Q39758,Q6TCF2,P51775,O81221,Q99023,P17128,Q9P4D1,P45520,P91754,O16808,O65316,P78711,O74258,Q39596,P53689,P13363,A5DQP9,P24902,P81085,P45521,P50138,P60011,O65314,P10989,Q11212,O00937,P68555,P10365,P53476,P53477,P20904,Q9UVF3,P60010">actin</z:uniprot> was stained with DyLight 488-phalloidin for 15 min in the dark according to the manufacturer's instructions. </plain></SENT>
<SENT sid="408" pm="."><plain>Images were obtained using a confocal microscope (Olympus FV10i) (original magnification: 600x, scale bar 50 μm). </plain></SENT>
</text></p></caption><graphic xlink:href="MI2017-8529542.008"/></fig></SecTag></floats-group></article>
